aluates Reports

$ 0.0

Automative

Global Pancreatic Endocrine Tumor Drug Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-25P9723

Global Pancreatic Endocrine Tumor Drug Market Insights Forecast to 2028

BUY CHAPTERS

Global Pancreatic Endocrine Tumor Drug Market Research Report 2025

Code: QYRE-Auto-25P9723

Report

January 2025

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ipsen S A

Jiangsu Hengrui Medicine Co Ltd

MediaPharma srl

Novartis

OXiGENE, Inc.

Pancreatic Endocrine Tumor Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pancreatic Endocrine Tumor Drug Market

The global market for Pancreatic Endocrine Tumor Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pancreatic Endocrine Tumor Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pancreatic Endocrine Tumor Drug.

The Pancreatic Endocrine Tumor Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pancreatic Endocrine Tumor Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pancreatic Endocrine Tumor Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pancreatic Endocrine Tumor Drug Market Report

Report Metric	Details
Report Name	Pancreatic Endocrine Tumor Drug Market
CAGR	5%
Segment by Type	Buparlisib Hydrochloride Dovitinib Lactate Fosbretabulin Tromethamine Lanreotide Acetate MPHE-001B Others
Segment by Application	Clinic Research Center Hospital
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Ipsen S.A., Jiangsu Hengrui Medicine Co., Ltd., MediaPharma s.r.l., Novartis AG, OXiGENE, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pancreatic Endocrine Tumor Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pancreatic Endocrine Tumor Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pancreatic Endocrine Tumor Drug Market report?

Ans: The main players in the Pancreatic Endocrine Tumor Drug Market are Ipsen S.A., Jiangsu Hengrui Medicine Co., Ltd., MediaPharma s.r.l., Novartis AG, OXiGENE, Inc.

What are the Application segmentation covered in the Pancreatic Endocrine Tumor Drug Market report?

Ans: The Applications covered in the Pancreatic Endocrine Tumor Drug Market report are Clinic, Research Center, Hospital

What are the Type segmentation covered in the Pancreatic Endocrine Tumor Drug Market report?

Ans: The Types covered in the Pancreatic Endocrine Tumor Drug Market report are Buparlisib Hydrochloride, Dovitinib Lactate, Fosbretabulin Tromethamine, Lanreotide Acetate, MPHE-001B, Others

Recommended Reports

Cancer Therapeutics

Tumor Targeted Drugs

Endocrine & Diabetic Drugs

1 Pancreatic Endocrine Tumor Drug Market Overview

1.1 Product Definition

1.2 Pancreatic Endocrine Tumor Drug by Type

1.2.1 Global Pancreatic Endocrine Tumor Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 Buparlisib Hydrochloride

1.2.3 Dovitinib Lactate

1.2.4 Fosbretabulin Tromethamine

1.2.5 Lanreotide Acetate

1.2.6 MPHE-001B

1.2.7 Others

1.3 Pancreatic Endocrine Tumor Drug by Application

1.3.1 Global Pancreatic Endocrine Tumor Drug Market Value by Application (2024 VS 2031)

1.3.2 Clinic

1.3.3 Research Center

1.3.4 Hospital

1.4 Global Pancreatic Endocrine Tumor Drug Market Size Estimates and Forecasts

1.4.1 Global Pancreatic Endocrine Tumor Drug Revenue 2020-2031

1.4.2 Global Pancreatic Endocrine Tumor Drug Sales 2020-2031

1.4.3 Global Pancreatic Endocrine Tumor Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Pancreatic Endocrine Tumor Drug Market Competition by Manufacturers

2.1 Global Pancreatic Endocrine Tumor Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pancreatic Endocrine Tumor Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pancreatic Endocrine Tumor Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pancreatic Endocrine Tumor Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pancreatic Endocrine Tumor Drug, Product Type & Application

2.7 Global Key Manufacturers of Pancreatic Endocrine Tumor Drug, Date of Enter into This Industry

2.8 Global Pancreatic Endocrine Tumor Drug Market Competitive Situation and Trends

2.8.1 Global Pancreatic Endocrine Tumor Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pancreatic Endocrine Tumor Drug Players Market Share by Revenue

2.8.3 Global Pancreatic Endocrine Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pancreatic Endocrine Tumor Drug Market Scenario by Region

3.1 Global Pancreatic Endocrine Tumor Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pancreatic Endocrine Tumor Drug Sales by Region: 2020-2031

3.2.1 Global Pancreatic Endocrine Tumor Drug Sales by Region: 2020-2025

3.2.2 Global Pancreatic Endocrine Tumor Drug Sales by Region: 2026-2031

3.3 Global Pancreatic Endocrine Tumor Drug Revenue by Region: 2020-2031

3.3.1 Global Pancreatic Endocrine Tumor Drug Revenue by Region: 2020-2025

3.3.2 Global Pancreatic Endocrine Tumor Drug Revenue by Region: 2026-2031

3.4 North America Pancreatic Endocrine Tumor Drug Market Facts & Figures by Country

3.4.1 North America Pancreatic Endocrine Tumor Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pancreatic Endocrine Tumor Drug Sales by Country (2020-2031)

3.4.3 North America Pancreatic Endocrine Tumor Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pancreatic Endocrine Tumor Drug Market Facts & Figures by Country

3.5.1 Europe Pancreatic Endocrine Tumor Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pancreatic Endocrine Tumor Drug Sales by Country (2020-2031)

3.5.3 Europe Pancreatic Endocrine Tumor Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pancreatic Endocrine Tumor Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Pancreatic Endocrine Tumor Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pancreatic Endocrine Tumor Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Pancreatic Endocrine Tumor Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pancreatic Endocrine Tumor Drug Market Facts & Figures by Country

3.7.1 Latin America Pancreatic Endocrine Tumor Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pancreatic Endocrine Tumor Drug Sales by Country (2020-2031)

3.7.3 Latin America Pancreatic Endocrine Tumor Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pancreatic Endocrine Tumor Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Pancreatic Endocrine Tumor Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pancreatic Endocrine Tumor Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pancreatic Endocrine Tumor Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Pancreatic Endocrine Tumor Drug Sales by Type (2020-2031)

4.1.1 Global Pancreatic Endocrine Tumor Drug Sales by Type (2020-2025)

4.1.2 Global Pancreatic Endocrine Tumor Drug Sales by Type (2026-2031)

4.1.3 Global Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2020-2031)

4.2 Global Pancreatic Endocrine Tumor Drug Revenue by Type (2020-2031)

4.2.1 Global Pancreatic Endocrine Tumor Drug Revenue by Type (2020-2025)

4.2.2 Global Pancreatic Endocrine Tumor Drug Revenue by Type (2026-2031)

4.2.3 Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Type (2020-2031)

4.3 Global Pancreatic Endocrine Tumor Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pancreatic Endocrine Tumor Drug Sales by Application (2020-2031)

5.1.1 Global Pancreatic Endocrine Tumor Drug Sales by Application (2020-2025)

5.1.2 Global Pancreatic Endocrine Tumor Drug Sales by Application (2026-2031)

5.1.3 Global Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2020-2031)

5.2 Global Pancreatic Endocrine Tumor Drug Revenue by Application (2020-2031)

5.2.1 Global Pancreatic Endocrine Tumor Drug Revenue by Application (2020-2025)

5.2.2 Global Pancreatic Endocrine Tumor Drug Revenue by Application (2026-2031)

5.2.3 Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Application (2020-2031)

5.3 Global Pancreatic Endocrine Tumor Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Ipsen S.A.

6.1.1 Ipsen S.A. Company Information

6.1.2 Ipsen S.A. Description and Business Overview

6.1.3 Ipsen S.A. Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Ipsen S.A. Pancreatic Endocrine Tumor Drug Product Portfolio

6.1.5 Ipsen S.A. Recent Developments/Updates

6.2 Jiangsu Hengrui Medicine Co., Ltd.

6.2.1 Jiangsu Hengrui Medicine Co., Ltd. Company Information

6.2.2 Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview

6.2.3 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Product Portfolio

6.2.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates

6.3 MediaPharma s.r.l.

6.3.1 MediaPharma s.r.l. Company Information

6.3.2 MediaPharma s.r.l. Description and Business Overview

6.3.3 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Product Portfolio

6.3.5 MediaPharma s.r.l. Recent Developments/Updates

6.4 Novartis AG

6.4.1 Novartis AG Company Information

6.4.2 Novartis AG Description and Business Overview

6.4.3 Novartis AG Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Novartis AG Pancreatic Endocrine Tumor Drug Product Portfolio

6.4.5 Novartis AG Recent Developments/Updates

6.5 OXiGENE, Inc.

6.5.1 OXiGENE, Inc. Company Information

6.5.2 OXiGENE, Inc. Description and Business Overview

6.5.3 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Product Portfolio

6.5.5 OXiGENE, Inc. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pancreatic Endocrine Tumor Drug Industry Chain Analysis

7.2 Pancreatic Endocrine Tumor Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pancreatic Endocrine Tumor Drug Production Mode & Process Analysis

7.4 Pancreatic Endocrine Tumor Drug Sales and Marketing

7.4.1 Pancreatic Endocrine Tumor Drug Sales Channels

7.4.2 Pancreatic Endocrine Tumor Drug Distributors

7.5 Pancreatic Endocrine Tumor Drug Customer Analysis

8 Pancreatic Endocrine Tumor Drug Market Dynamics

8.1 Pancreatic Endocrine Tumor Drug Industry Trends

8.2 Pancreatic Endocrine Tumor Drug Market Drivers

8.3 Pancreatic Endocrine Tumor Drug Market Challenges

8.4 Pancreatic Endocrine Tumor Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Ipsen S A

Jiangsu Hengrui Medicine Co Ltd

MediaPharma srl

Novartis

OXiGENE, Inc.

List of Tables

Table 1. Global Pancreatic Endocrine Tumor Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pancreatic Endocrine Tumor Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Pancreatic Endocrine Tumor Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Pancreatic Endocrine Tumor Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Pancreatic Endocrine Tumor Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Pancreatic Endocrine Tumor Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Pancreatic Endocrine Tumor Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pancreatic Endocrine Tumor Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pancreatic Endocrine Tumor Drug, Product Type & Application

Table 12. Global Key Manufacturers of Pancreatic Endocrine Tumor Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pancreatic Endocrine Tumor Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Endocrine Tumor Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pancreatic Endocrine Tumor Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Pancreatic Endocrine Tumor Drug Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Region (2020-2025)

Table 19. Global Pancreatic Endocrine Tumor Drug Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Region (2026-2031)

Table 21. Global Pancreatic Endocrine Tumor Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Pancreatic Endocrine Tumor Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Pancreatic Endocrine Tumor Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Pancreatic Endocrine Tumor Drug Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Pancreatic Endocrine Tumor Drug Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Pancreatic Endocrine Tumor Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Pancreatic Endocrine Tumor Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Pancreatic Endocrine Tumor Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Pancreatic Endocrine Tumor Drug Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Pancreatic Endocrine Tumor Drug Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Pancreatic Endocrine Tumor Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Pancreatic Endocrine Tumor Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Pancreatic Endocrine Tumor Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Pancreatic Endocrine Tumor Drug Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Pancreatic Endocrine Tumor Drug Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Pancreatic Endocrine Tumor Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Pancreatic Endocrine Tumor Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Pancreatic Endocrine Tumor Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Pancreatic Endocrine Tumor Drug Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Pancreatic Endocrine Tumor Drug Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Pancreatic Endocrine Tumor Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pancreatic Endocrine Tumor Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Pancreatic Endocrine Tumor Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Pancreatic Endocrine Tumor Drug Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Pancreatic Endocrine Tumor Drug Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Pancreatic Endocrine Tumor Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Pancreatic Endocrine Tumor Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Type (2020-2025)

Table 51. Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Type (2026-2031)

Table 52. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2020-2025)

Table 53. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2026-2031)

Table 54. Global Pancreatic Endocrine Tumor Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Pancreatic Endocrine Tumor Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Pancreatic Endocrine Tumor Drug Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Pancreatic Endocrine Tumor Drug Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Application (2020-2025)

Table 61. Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Application (2026-2031)

Table 62. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2020-2025)

Table 63. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2026-2031)

Table 64. Global Pancreatic Endocrine Tumor Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Pancreatic Endocrine Tumor Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Pancreatic Endocrine Tumor Drug Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Pancreatic Endocrine Tumor Drug Price (USD/Pcs) by Application (2026-2031)

Table 70. Ipsen S.A. Company Information

Table 71. Ipsen S.A. Description and Business Overview

Table 72. Ipsen S.A. Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. Ipsen S.A. Pancreatic Endocrine Tumor Drug Product

Table 74. Ipsen S.A. Recent Developments/Updates

Table 75. Jiangsu Hengrui Medicine Co., Ltd. Company Information

Table 76. Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview

Table 77. Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Product

Table 79. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates

Table 80. MediaPharma s.r.l. Company Information

Table 81. MediaPharma s.r.l. Description and Business Overview

Table 82. MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Product

Table 84. MediaPharma s.r.l. Recent Developments/Updates

Table 85. Novartis AG Company Information

Table 86. Novartis AG Description and Business Overview

Table 87. Novartis AG Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. Novartis AG Pancreatic Endocrine Tumor Drug Product

Table 89. Novartis AG Recent Developments/Updates

Table 90. OXiGENE, Inc. Company Information

Table 91. OXiGENE, Inc. Description and Business Overview

Table 92. OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Product

Table 94. OXiGENE, Inc. Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Pancreatic Endocrine Tumor Drug Distributors List

Table 98. Pancreatic Endocrine Tumor Drug Customers List

Table 99. Pancreatic Endocrine Tumor Drug Market Trends

Table 100. Pancreatic Endocrine Tumor Drug Market Drivers

Table 101. Pancreatic Endocrine Tumor Drug Market Challenges

Table 102. Pancreatic Endocrine Tumor Drug Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pancreatic Endocrine Tumor Drug

Figure 2. Global Pancreatic Endocrine Tumor Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pancreatic Endocrine Tumor Drug Market Share by Type: 2024 & 2031

Figure 4. Buparlisib Hydrochloride Product Picture

Figure 5. Dovitinib Lactate Product Picture

Figure 6. Fosbretabulin Tromethamine Product Picture

Figure 7. Lanreotide Acetate Product Picture

Figure 8. MPHE-001B Product Picture

Figure 9. Others Product Picture

Figure 10. Global Pancreatic Endocrine Tumor Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Pancreatic Endocrine Tumor Drug Market Share by Application: 2024 & 2031

Figure 12. Clinic

Figure 13. Research Center

Figure 14. Hospital

Figure 15. Global Pancreatic Endocrine Tumor Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Pancreatic Endocrine Tumor Drug Market Size (2020-2031) & (US$ Million)

Figure 17. Global Pancreatic Endocrine Tumor Drug Sales (2020-2031) & (K Pcs)

Figure 18. Global Pancreatic Endocrine Tumor Drug Average Price (USD/Pcs) & (2020-2031)

Figure 19. Pancreatic Endocrine Tumor Drug Report Years Considered

Figure 20. Pancreatic Endocrine Tumor Drug Sales Share by Manufacturers in 2024

Figure 21. Global Pancreatic Endocrine Tumor Drug Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Pancreatic Endocrine Tumor Drug Players: Market Share by Revenue in Pancreatic Endocrine Tumor Drug in 2024

Figure 23. Pancreatic Endocrine Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Pancreatic Endocrine Tumor Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Pancreatic Endocrine Tumor Drug Sales Market Share by Country (2020-2031)

Figure 26. North America Pancreatic Endocrine Tumor Drug Revenue Market Share by Country (2020-2031)

Figure 27. U.S. Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Country (2020-2031)

Figure 30. Europe Pancreatic Endocrine Tumor Drug Revenue Market Share by Country (2020-2031)

Figure 31. Germany Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Pancreatic Endocrine Tumor Drug Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Pancreatic Endocrine Tumor Drug Revenue Market Share by Region (2020-2031)

Figure 38. China Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Taiwan Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Indonesia Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Thailand Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Malaysia Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Philippines Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Latin America Pancreatic Endocrine Tumor Drug Sales Market Share by Country (2020-2031)

Figure 49. Latin America Pancreatic Endocrine Tumor Drug Revenue Market Share by Country (2020-2031)

Figure 50. Mexico Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Brazil Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Argentina Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Middle East and Africa Pancreatic Endocrine Tumor Drug Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Pancreatic Endocrine Tumor Drug Revenue Market Share by Country (2020-2031)

Figure 55. Turkey Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. U.A.E Pancreatic Endocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Global Sales Market Share of Pancreatic Endocrine Tumor Drug by Type (2020-2031)

Figure 59. Global Revenue Market Share of Pancreatic Endocrine Tumor Drug by Type (2020-2031)

Figure 60. Global Pancreatic Endocrine Tumor Drug Price (USD/Pcs) by Type (2020-2031)

Figure 61. Global Sales Market Share of Pancreatic Endocrine Tumor Drug by Application (2020-2031)

Figure 62. Global Revenue Market Share of Pancreatic Endocrine Tumor Drug by Application (2020-2031)

Figure 63. Global Pancreatic Endocrine Tumor Drug Price (USD/Pcs) by Application (2020-2031)

Figure 64. Pancreatic Endocrine Tumor Drug Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Pancreatic Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neuroendocrine Tumor Drug Market Research Report 2024

Gastroenteropancreatic Neuroendocrine Tumor Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neuroendocrine Carcinoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Endocrine Therapy Drugs for Breast Cancer Market Research Report 2024

Solid Tumor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Insulin Drugs Market Research Report 2025

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Global Intratumoral Cancer Therapies Market Research Report 2025

Rare Endocrine Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diabetes Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetic Therapeutic Drugs Market Research Report 2025

Pancreatic Cancer Diagnostic Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neuroendocrine Carcinoma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neuroendocrine Tumor NET Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Brain Tumor Diagnostics and Therapeutics Market Research Report 2024

Global Non Insulin Hypoglycemic Drug Market Research Report 2025

Global Small Molecule Cancer Drug Market Research Report 2025

Tumor Immunotherapy Market

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions